stock.name

Biocryst Pharmaceuticals Inc.

BCRX

Market Cap$1.13B
Close$

Compare Biocryst Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biocryst Pharmaceuticals Inc.Biocryst Pharmaceuticals Inc.-50%50%5.2-1.8
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$8.03

Current Fair Value

55.8% upside

Undervalued by 55.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.13 Billion
Enterprise Value$1.58 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.18
Beta1.0
Outstanding Shares206,149,929
Avg 30 Day Volume3,409,401

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-5.0
PEG36.43
Price to Sales5.15
Price to Book Ratio-1.72
Enterprise Value to Revenue4.77
Enterprise Value to EBIT-15.25
Enterprise Value to Net Income-7
Total Debt to Enterprise0.53
Debt to Equity-1.84

Revenue Sources

No data

ESG Score

No data

About Biocryst Pharmaceuticals Inc.

CEO: Jon Stonehouse